Delivery Order SPE2DB20D3505-SPE2DB25FU3D3
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.92 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $7,963.75, and an ultimate completion date of July 26, 2024. The award covers the procurement of EUCRISA 2% Ointment 60GM, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The federal contract award with ID SPE2DX15D1053|SPE2DX25F6ESM was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,219.36 firm fixed-price delivery order is for EUCRISA 2% ointment, a pharmaceutical product, and has an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, with a ceiling value of $3,629.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), is for the provision of EUCRISA 2% ointment, a prescription medication. The contract has a period of performance through November 28, 2023 and utilizes a firm fixed-price pricing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.67, is for the delivery of EUCRISA 2% ointment 60GM. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award, valued at $1,299.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product EUCRISA 2% Ointment 60GM. It has an ultimate completion date of May 7, 2024 and a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D1041|SPE2DB24FTXX4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,389.19 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, with an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award (SPE2DB20D3505|SPE2DB24FT5B9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,939.73 firm fixed-price delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DX15D7056|SPE2DX24F1UDE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of EUCRISA 2% ointment in 60 gram tubes. The firm fixed price delivery order has a ceiling value of $1,341.26 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is the prime...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,612.76 firm fixed-price delivery order is for the supply of the pharmaceutical product EUCRISA 2% Ointment 60GM. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a...